Evaluation of bacteremia in a pediatric intensive care unit: epidemiology, microbiology, sources sites and risk

Branka Maldini1, Stanko Antolić, Katarina Sakić-Zdravcević

  • 1Department of Anesthesia and Intensive Care Unit, General Hospital "Sveti Duh", Zagreb, Croatia. branka.maldini@zg.t-com.hr

Collegium Antropologicum
|January 26, 2008
PubMed

Insights

This study identified common causes of bacteremia in a pediatric intensive care unit (PICU), finding coagulase-negative staphylococci and Candida species most frequent. Prompt diagnosis and treatment are crucial for reducing pediatric bacteremia mortality.

Area of Science:

  • Pediatric Intensive Care
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Bacteremia is a significant cause of illness and death in pediatric intensive care units (PICUs).
  • Understanding the specific pathogens and risk factors is vital for effective management.

Purpose of the Study:

  • To investigate the causative agents of bacteremia in a PICU over one year.
  • To determine mortality rates associated with bacteremia.
  • To identify predictors of morbidity and mortality in pediatric bacteremia cases.

Main Methods:

  • Prospective data collection from 479 patients admitted to the PICU over a one-year period.
  • 379 blood cultures analyzed using the BACTEC 9050 System and standard microbiological methods.
  • Data on patient demographics, predisposing conditions, infection sources, clinical parameters, and microbiological findings were recorded.

Main Results:

  • 117 episodes of bacteremia were documented in 72 patients.
  • Coagulase-negative staphylococci (32.2%) and Candida spp. (30.5%) were the most common isolates.
  • Intravascular catheters (22.6%) and pneumonia (20.4%) were the leading sources of infection; seven patients died from sepsis.

Conclusions:

  • Coagulase-negative staphylococci and Candida spp. are primary bacteremia culprits in this PICU.
  • Early diagnosis, rapid blood culture results, and appropriate antibiotic therapy are essential for reducing mortality.
  • Minimizing hospital stay duration and invasive device use can help reduce bacteremia risk in PICU patients.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...